weekly glp 1 agonist GLP-1 Receptor Market Size & Analysis, 2026-2033 GLP-1 Receptor Agonist Market Size

LK and ZX performed the experiments and wrote the manuscript

The co-administration of laropiprant a prostaglandin D2 receptor-1 antagonist helps reduce nicotinic acid-induced skin flushing

Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

RCT, randomized controlled trial

457 The basket trial of KY100001K uses IDH mutation as the core enrollment criterion, overcoming tumor tissue-of-origin constraints to efficiently evaluate its efficacy and safety across multiple cancer types, thereby accelerating the precise development of rare molecular subtypes and providing a rationale for pancancer applications